#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	5230	16S	1529	1529	99.93	16S.l6.c4.ctg.1	1944	465.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1624	1624	T	486	T	276	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	5230	16S	1529	1529	99.93	16S.l6.c4.ctg.1	1944	465.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1358	1358	C	549	C	318	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8942	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3740	403.1	0	.	n	.	0	A9G	SNP	9	9	A	394	394	G	454	G	266	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8942	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3740	403.1	0	.	n	.	0	T695C	SNP	695	695	T	1080	1080	C	494	C	281	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8942	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3740	403.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2356	2356	C	445	C	265	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8942	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3740	403.1	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2982	2982	T	458	T,C	272,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8942	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3740	403.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2430	2430	A	472	A	285	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	527	298	folP	855	855	99.77	folP.l6.c30.ctg.1	1648	32.7	1	SNP	p	R229S	1	.	.	685	687	AGC	979	981	AGC	38;38;38	A;G;C	24;23;24	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	527	298	folP	855	183	93.99	folP.l6.c30.ctg.2	495	0.7	0	.	p	.	0	W93G	NONSYN	277	279	TGG	107	109	GGG	1;1;1	G;G;G	0;1;1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	527	298	folP	855	183	93.99	folP.l6.c30.ctg.2	495	0.7	0	.	p	.	0	P96S	NONSYN	286	288	CCC	116	118	TCC	1;1;1	T,C;C;C	0,1;1;1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	527	298	folP	855	183	93.99	folP.l6.c30.ctg.2	495	0.7	0	.	p	.	0	V97H	NONSYN	289	291	GTC	119	121	CAC	1;1;1	C;A;C	0;0;0	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	527	298	folP	855	183	93.99	folP.l6.c30.ctg.2	495	0.7	0	.	p	.	0	V106G	NONSYN	316	318	GTT	146	148	GGT	1;1;1	G;G;T	1;0;1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	527	298	folP	855	183	93.99	folP.l6.c30.ctg.2	495	0.7	0	.	p	.	0	M107L	NONSYN	319	321	ATG	149	151	TTG	1;1;1	T;T;G	1;1;0	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	527	298	folP	855	183	93.99	folP.l6.c30.ctg.2	495	0.7	0	.	p	.	0	E108G	NONSYN	322	324	GAA	152	154	GGA	1;1;1	G;G;A	1;0;1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	527	298	folP	855	183	93.99	folP.l6.c30.ctg.2	495	0.7	0	.	p	.	0	A112G	NONSYN	334	336	GCA	164	166	GGA	1;1;1	G;G;A	1;0;1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	527	298	folP	855	183	93.99	folP.l6.c30.ctg.2	495	0.7	0	.	p	.	0	I116L	NONSYN	346	348	ATC	176	178	CTC	1;1;1	C;T;C	0;1;1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	527	298	folP	855	183	93.99	folP.l6.c30.ctg.2	495	0.7	0	.	p	.	0	D117G	NONSYN	349	351	GAT	179	181	GGT	1;1;1	G;G;T	1;0;1	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	517	884	gyrA	2751	583	99.83	gyrA.l15.c4.ctg.1	945	24.5	0	.	p	.	0	N758fs	FSHIFT	2272	2272	A	103	103	A	5	A	1	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	517	884	gyrA	2751	2371	99.58	gyrA.l15.c4.ctg.2	2700	47.2	0	.	p	.	0	T243I	NONSYN	727	729	ACA	1056	1058	ATA	50;49;42	A;T;A	33;33;29	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	517	884	gyrA	2751	2371	99.58	gyrA.l15.c4.ctg.2	2700	47.2	0	.	p	.	0	M250I	NONSYN	748	750	ATG	1077	1079	ATA	34;34;34	A;T;A	24;24;24	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	517	884	gyrA	2751	2371	99.58	gyrA.l15.c4.ctg.2	2700	47.2	0	.	p	.	0	L775P	NONSYN	2323	2325	CTG	2652	2654	CCG	4;2;2	C;C,T;G	2;0,1;1	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	517	884	gyrA	2751	2371	99.58	gyrA.l15.c4.ctg.2	2700	47.2	0	.	p	.	0	D778G	NONSYN	2332	2334	GAC	2661	2663	GGC	2;2;2	G;G;C	1;0;1	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	517	884	gyrA	2751	2371	99.58	gyrA.l15.c4.ctg.2	2700	47.2	0	.	p	.	0	I781N	NONSYN	2341	2343	ATC	2670	2672	AAC	2;2;2	A;A,T;C	1;0,1;1	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	517	884	gyrA	2751	2371	99.58	gyrA.l15.c4.ctg.2	2700	47.2	0	.	p	.	0	V782G	NONSYN	2344	2346	GTC	2673	2675	GGC	2;2;2	G;G,T;C	1;0,1;1	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	517	884	gyrA	2751	2371	99.58	gyrA.l15.c4.ctg.2	2700	47.2	1	SNP	p	S91F	0	.	.	271	273	TCC	600	602	TCC	57;59;59	T;C;C	29;30;31	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	517	884	gyrA	2751	2371	99.58	gyrA.l15.c4.ctg.2	2700	47.2	1	SNP	p	D95G	0	.	.	283	285	GAC	612	614	GAC	62;62;62	G;A;C	34;34;34	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	517	884	gyrA	2751	2371	99.58	gyrA.l15.c4.ctg.2	2700	47.2	1	SNP	p	D95N	0	.	.	283	285	GAC	612	614	GAC	62;62;62	G;A;C	34;34;34	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	531	218	mtrR	633	633	99.69	mtrR.l15.c4.ctg.1	1264	32.2	0	.	p	.	0	P191fs	FSHIFT	571	571	C	873	873	C	40	C	25	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	531	218	mtrR	633	633	99.69	mtrR.l15.c4.ctg.1	1264	32.2	1	SNP	p	G45D	0	.	.	133	135	GGC	434	436	GGC	66;66;66	G;G;C	41;41;40	mtrR.WHO_F_01564:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	196	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	815	41.0	0	.	n	.	0	.206T	INS	206	206	T	524	524	T	89	T	50	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	782	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3000	44.6	0	.	p	.	0	V421A	NONSYN	1261	1263	GTC	1598	1600	GCC	54;54;46	G;C;C	32;32;27	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	782	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3000	44.6	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1640	1642	GCA	44;44;44	G;C;A	26;25;25	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	782	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3000	44.6	1	SNP	p	D86N	0	.	.	256	258	GAC	593	595	GAC	72;74;74	G;A;C,A	45;43;43,1	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	782	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3000	44.6	1	SNP	p	S87R	0	.	.	259	261	AGT	596	598	AGT	74;76;77	A;G;T	43;46;45	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	782	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3000	44.6	1	SNP	p	S87I	0	.	.	259	261	AGT	596	598	AGT	74;76;77	A;G;T	43;46;45	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	782	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3000	44.6	1	SNP	p	S87W	0	.	.	259	261	AGT	596	598	AGT	74;76;77	A;G;T	43;46;45	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	782	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3000	44.6	1	SNP	p	S88P	0	.	.	262	264	TCC	599	601	TCC	76;78;78	T;C,G;C,A	46;45,1;48,1	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_W_01411c	parE.WHO_W_01411c	1	1	27	708	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2741	45.7	1	SNP	p	G410V	0	.	.	1228	1230	GGT	1511	1513	GGT	39;39;39	G;G;T	25;25;23	parE.WHO_W_01411c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	976	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2111	76.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1126	1128	GCA	109;111;111	G,T;C;A	62,1;67;68	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	976	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2111	76.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1129	1131	ATC	111;111;111	A;T;C	68;66;67	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	976	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2111	76.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1141	1143	GTG	108;108;108	G;T;G	63;65;65	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	976	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2111	76.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1141	1143	GTG	108;108;108	G;T;G	63;65;65	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	976	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2111	76.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1645	1647	ACC	66;66;63	A;C;C	39;41;40	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	976	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2111	76.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1699	1701	GCG	55;54;54	G;C;G	33;32;32	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	976	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2111	76.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1699	1701	GCG	55;54;54	G;C;G	33;32;32	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	976	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2111	76.1	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1822	1824	GGT	64;64;63	G;G;T,G	39;39;40,1	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	976	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2111	76.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1831	1833	GGC	54;58;57	G;G;C	34;37;36	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	976	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2111	76.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1849	1851	CCG	53;51;51	C;C;G	31;30;28	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1614	ponA	2397	2397	99.96	ponA.l15.c17.ctg.1	3014	84.7	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1614	1616	CTG	63;63;63	C;T;G	33;36;38	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	412	porA	1146	1146	99.65	porA.l6.c4.ctg.1	1772	40.7	0	.	p	.	0	S22G	NONSYN	64	66	AGC	400	402	GGC	46;46;46	G;G;C	30;29;28	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	412	porA	1146	1146	99.65	porA.l6.c4.ctg.1	1772	40.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	582	582	C	28	C	16	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	462	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1539	52.9	0	.	p	.	0	T18M	NONSYN	52	54	ACG	272	274	ATG	70;71;71	A;T,A;G	38;38,1;37	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	462	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1539	52.9	0	.	p	.	0	I45V	NONSYN	133	135	ATT	353	355	GTT	61;59;59	G;T;T	34;34;33	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	462	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1539	52.9	0	.	p	.	0	N121S	NONSYN	361	363	AAC	581	583	AGC	36;36;36	A;G;C	22;21;24	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	462	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1539	52.9	0	.	p	.	0	N122K	NONSYN	364	366	AAC	584	586	AAA	36;36;36	A;A;A	23;24;24	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	462	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1539	52.9	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	611	613	TAT	42;42;42	T;A;T	26;26;27	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	462	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1539	52.9	0	.	p	.	0	N134K	NONSYN	400	402	AAT	620	622	AAG	42;42;42	A;A;G	27;28;27	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	462	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1539	52.9	0	.	p	.	0	V135F	NONSYN	403	405	GTG	623	625	TTT	42;42;42	T;T;T	27;26;27	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	462	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1539	52.9	0	.	p	.	0	G140K	NONSYN	418	420	GGA	638	640	AAA	42;42;42	A;A;A	28;28;28	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	462	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1539	52.9	0	.	p	.	0	Q143E	NONSYN	427	429	CAA	647	649	GAA	45;50;51	G;A;A	29;32;32	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	462	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1539	52.9	0	.	p	.	0	V151A	NONSYN	451	453	GTA	671	673	GCA	53;54;55	G;C;A	31;32;32	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	462	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1539	52.9	0	.	p	.	0	K207_M208insK	INS	619	619	A	839	839	A	82	A	47	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	462	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1539	52.9	0	.	p	.	0	A212S	NONSYN	634	636	GCA	857	859	TCA	92;94;95	T;C;A	53;54;54	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	462	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1539	52.9	0	.	p	.	0	Y251fs	FSHIFT	751	751	T	974	974	T	74	T	42	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	2356	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4866	83.8	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1975	1977	CAT	99;101;101	C;A;T	58;61;58	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	230	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	997	41.8	1	SNP	p	V57M	1	.	.	169	171	ATG	450	452	ATG	84;81;81	A;T;G	48;45;46	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
